Daly James M

SEC CIK: 0001560782

SEC filings (opens in a new tab)

In the past year, 1 open-market sale filing worth $671.1K and no purchases.

Current role at each company

CYTK Cytokinetics IncDirectoras of Jul 16, 2026
MDGL Madrigal Pharmaceuticals, Inc.Directoras of Jun 18, 2026
ACAD Acadia Pharmaceuticals IncDirectoras of Jun 1, 2026
HALO Halozyme Therapeutics, Inc.Directoras of Aug 15, 2023
Bellicum Pharmaceuticals, IncDirectoras of Jan 5, 2023

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought: –; 0 filings
Sold: $671.1K; 1 filing
Net: −$671.1K; Bought minus sold
Companies: 1; With open-market trades

Trades

Every Form 4 that lists Daly James M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Transaction type

Role

Minimum value (USD)

Filed from

Filed to

Filing delay at least (days)

Filing delay at most (days)

ACAD Acadia Pharmaceuticals Inc

Director1 trade

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 12, 2025 (view filing)	Nov 10	2 days	Daly James MDirector	SSale	−30.0K	$22.37	−$671.1K	−88.1%4.04K after

MDGL Madrigal Pharmaceuticals, Inc.

Director2 trades

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Feb 28, 2025 (view filing)	Feb 27	1 day	Daly James MDirector	SSale	−15.5K	$347.45	−$5.38M	−89.0%1.91K after	3 lots
Apr 3, 2024 (view filing)	Apr 1-2	2 days	Daly James MDirector	SSale	−32.5K	$252.97	−$8.22M	−96.4%1.20K after	16 lots10b5-1

HALO Halozyme Therapeutics, Inc.